Genetic factors are well-recognized to play an important role in the pathogenesis of Alzheimer's disease (AD). This is best unerstood for the genes causing early onset familial AD (EOAD), namely APP, PS1 and PS2. A single genetic factor influencing age of onset in late onset AD (LOAD) is also recognized, namely ApoE. Nevertheless, there still exist large gaps in our understanding of the genetic aspects of AD including additional genetic factors impacting age of onset, penetrance and phenotypic expression of both EAOD and LOAD. Furthermore, it is clear that many other types of hereditary dementia overlap clinically, pathologically and molecularly with AD, as well as being important in their own right. The purpose of the UW ADRC Genetics Core is to provide a unique resource of family material and genotyping information to qualified investigators to advance our understanding of genetic factors in AD and other dementing illnesses.
The Specific Aims are:
Specific Aim 1 : To recruit, characterize, sample and follow families with Alzheimer's disease and other forms of dementia. Phenotypic data and samples from these families will be made available to investigators in the U W ADRC and other appropriate scientists at the University of Washington and other institutions.
Specific Aim 2 : Provide serum/plasma/DNA banking for studies of AD and other dementias.
Specific Aim 3 : Provide genotyping and mutational analysis for AD and dementia studies including (a) apolipoprotein (APOE) genotyping, (b) APOE haplotyping for 20 SNP sites including promoter polymorphisms and (c) mutation screening for known dementia genes including presenilins 1 and 2 (PSEN1,PSEN2), the prion gene (PRNP), MAPT (gene for tau), a-synuclein (ASN), parkin and DJ-1.
Specific Aim 4 : Provide genotyping and mutational anlysis for new dementia genes and polymorphic sites identified other AD investigators. Materials and information from this Core will be made available to collaborators within the UW ADRC, the UW Health Sciences Complex and all other relevant investigators in the US and worldwide.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG005136-23
Application #
7309667
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2006-05-01
Budget End
2007-04-30
Support Year
23
Fiscal Year
2006
Total Cost
$128,602
Indirect Cost
Name
University of Washington
Department
Type
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Agogo, George O; Ramsey, Christine M; Gnjidic, Danijela et al. (2018) Longitudinal associations between different dementia diagnoses and medication use jointly accounting for dropout. Int Psychogeriatr 30:1477-1487
Keene, C Dirk; Wilson, Angela M; Kilgore, Mitchell D et al. (2018) Luminex-based quantification of Alzheimer's disease neuropathologic change in formalin-fixed post-mortem human brain tissue. Lab Invest :
Locke, Timothy M; Soden, Marta E; Miller, Samara M et al. (2018) Dopamine D1 Receptor-Positive Neurons in the Lateral Nucleus of the Cerebellum Contribute to Cognitive Behavior. Biol Psychiatry 84:401-412
Flanagan, Margaret E; Cholerton, Brenna; Latimer, Caitlin S et al. (2018) TDP-43 Neuropathologic Associations in the Nun Study and the Honolulu-Asia Aging Study. J Alzheimers Dis 66:1549-1558
Edlow, Brian L; Keene, C Dirk; Perl, Daniel P et al. (2018) Multimodal Characterization of the Late Effects of Traumatic Brain Injury: A Methodological Overview of the Late Effects of Traumatic Brain Injury Project. J Neurotrauma 35:1604-1619
Mukherjee, Shubhabrata; Mez, Jesse; Trittschuh, Emily H et al. (2018) Genetic data and cognitively defined late-onset Alzheimer's disease subgroups. Mol Psychiatry :
Akhter, Rumana; Shao, Yvonne; Shaw, McKenzie et al. (2018) Regulation of ADAM10 by miR-140-5p and potential relevance for Alzheimer's disease. Neurobiol Aging 63:110-119
Crum, Jana; Wilson, Jeffrey; Sabbagh, Marwan (2018) Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia? Alzheimers Res Ther 10:104
Turk, Katherine W; Flanagan, Margaret E; Josephson, Samuel et al. (2018) Psychosis in Spinocerebellar Ataxias: a Case Series and Study of Tyrosine Hydroxylase in Substantia Nigra. Cerebellum 17:143-151
Petyuk, Vladislav A; Chang, Rui; Ramirez-Restrepo, Manuel et al. (2018) The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target. Brain 141:2721-2739

Showing the most recent 10 out of 753 publications